Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy

被引：24

作者：

Crescenzo, Francesco ^{[1
]}

Marastoni, Damiano ^{[1
]}

Bovo, Chiara ^{[2
]}

Calabrese, Massimiliano ^{[1
]}

机构：

[1] Univ Hosp Verona, Neurol Sect, Dept Neurosci Biomed & Movement Sci, Verona, Italy

[2] Univ Hosp Verona, Med Direct, Verona, Italy

来源：

MULTIPLE SCLEROSIS AND RELATED DISORDERS | 2020年 / 44卷

关键词：

COVID-19; coronavirus; multiple sclerosis;

D O I：

10.1016/j.msard.2020.102372

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Neurologists are interested in understanding whether patients with multiple sclerosis (pwMS) undergoing immunomodulatory/immunosuppressive therapy are more susceptible to developing COVID-19 or have worse outcomes. Currently, there are no conclusive data in this regard. We report the prevalence and severity of COVID-19 (confirmed and possible) in pwMS followed at the Veneto Regional MS Center in Verona (Italy), an area most stricken by COVID-19. In our sample size, the prevalence of COVID-19 seems to be much higher than that officially reported at the regional level on the general population, but it also characterized by a favourable course.

引用

页数：3

共 8 条

[1] COVID-19 and MS disease-modifying therapies [J].

Berger, Joseph R. ;

Brandstadter, Rachel ;

Bar-Or, Amit .

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2020, 7 (04)

[2] Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study [J].

Chen, Nanshan ;

Zhou, Min ;

Dong, Xuan ;

Qu, Jieming ;

Gong, Fengyun ;

Han, Yang ;

Qiu, Yang ;

Wang, Jingli ;

Liu, Ying ;

Wei, Yuan ;

Xia, Jia'an ;

Yu, Ting ;

Zhang, Xinxin ;

Zhang, Li .

LANCET, 2020, 395 (10223) :507-513

[3]

Flaxman S, 2020, ESTIMATING NUMBER IN, DOI [10.25561/77731, DOI 10.25561/77731]

[4] The COVID-19 pandemic and the use of MS disease-modifying therapies [J].

Giovannoni, Gavin ;

Hawkes, Chris ;

Lechner-Scott, Jeannette ;

Levy, Michael ;

Waubant, Emmanuelle ;

Gold, Julian .

MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 39

[5] Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain [J].

Montero-Escribano, Paloma ;

Matias-Guiu, Jorge ;

Gomez-Iglesias, Patricia ;

Porta-Etessam, Jesus ;

Pytel, Vanesa ;

Matias-Guiu, Jordi A. .

MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 42

[6] COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role? [J].

Novi, Giovanni ;

Mikulska, Malgorzata ;

Briano, Federica ;

Toscanini, Federica ;

Tazza, Francesco ;

Uccelli, Antonio ;

Inglese, Matilde .

MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 42

[7] Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy [J].

Onder, Graziano ;

Rezza, Giovanni ;

Brusaferro, Silvio .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (18) :1775-1776

[8] An Italian programme for COVID-19 infection in multiple sclerosis [J].

Sormani, Maria Pia .

LANCET NEUROLOGY, 2020, 19 (06) :481-482

← 1 →